Literature DB >> 12580945

Verotoxin 1 binding to intestinal crypt epithelial cells results in localization to lysosomes and abrogation of toxicity.

D E Elaine Hoey1, Linda Sharp, Carol Currie, Clifford A Lingwood, David L Gally, David G E Smith.   

Abstract

Verotoxins (VTs) are important virulence factors of enterohaemorrhagic Escherichia coli (EHEC), a group of bacteria associated with severe disease sequelae in humans. The potent cytotoxic activity of VTs is important in pathogenicity, resulting in the death of cells expressing receptor Gb3 (globotriaosylceramide). EHEC, particularly serotype O157:H7, frequently colonize reservoir hosts (such as cattle) in the absence of disease, however, the basis to avirulence in this host has been unclear. The objective of this study was assessment of interaction between VT and intestinal epithelium, which represents the major interface between the host and enteric organisms. Bovine intestinal epithelial cells expressed Gb3 in vitro in primary cell cultures, localizing specifically to proliferating crypt cells in corroboration with in situ immunohistological observations on intestinal mucosa. Expression of receptor by these cells contrasts with the absence of Gb3 on human intestinal epithelium in vivo. Despite receptor expression, VT exhibited no cytotoxic activity against bovine epithelial cells. Sub-cellular localization of VT indicated that this toxin was excluded from endoplasmic reticulum but localized to lysosomes, corresponding with abrogation of cytotoxicity. VT intracellular trafficking was unaffected by treatment of primary cell cultures with methyl-beta-cyclodextrin, indicating that Gb3 in these cells is not associated with lipid rafts but is randomly distributed in the membrane. The combination of Gb3 isoform, membrane distribution and VT trafficking correlate with observations of other receptor-positive cells that resist verocytotoxicity. These studies demonstrate that intestinal epithelium is an important determinant in VT interaction with major implications for the differential consequences of EHEC infection in reservoir hosts and humans.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12580945     DOI: 10.1046/j.1462-5822.2003.00254.x

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  32 in total

1.  The glycosphingolipid globotriaosylceramide in the metastatic transformation of colon cancer.

Authors:  Olga Kovbasnjuk; Rakhilya Mourtazina; Boris Baibakov; Thomas Wang; Christian Elowsky; Michael A Choti; Anne Kane; Mark Donowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-19       Impact factor: 11.205

Review 2.  Glycosphingolipid functions.

Authors:  Clifford A Lingwood
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-07-01       Impact factor: 10.005

Review 3.  Shiga toxin pathogenesis: kidney complications and renal failure.

Authors:  Tom G Obrig; Diana Karpman
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

Review 4.  Induction of apoptosis by Shiga toxins.

Authors:  Vernon L Tesh
Journal:  Future Microbiol       Date:  2010-03       Impact factor: 3.165

5.  Comparison of virulence gene profiles of Escherichia coli strains isolated from healthy and diarrheic swine.

Authors:  Toni A Chapman; Xi-Yang Wu; Idris Barchia; Karl A Bettelheim; Steven Driesen; Darren Trott; Mark Wilson; James J-C Chin
Journal:  Appl Environ Microbiol       Date:  2006-07       Impact factor: 4.792

6.  Development and characterization of 2-dimensional culture for buffalo intestinal cells.

Authors:  Nidhi Chaudhary; Himanshu Agrawal; Mamta Pandey; Suneel Onteru; Dheer Singh
Journal:  Cytotechnology       Date:  2017-10-14       Impact factor: 2.058

7.  Shiga toxin glycosphingolipid receptors in microvascular and macrovascular endothelial cells: differential association with membrane lipid raft microdomains.

Authors:  Josefine Betz; Martina Bielaszewska; Andrea Thies; Hans-Ulrich Humpf; Klaus Dreisewerd; Helge Karch; Kwang S Kim; Alexander W Friedrich; Johannes Müthing
Journal:  J Lipid Res       Date:  2011-01-20       Impact factor: 5.922

8.  Serotypes and virulence gene profiles of shiga toxin-producing Escherichia coli strains isolated from feces of pasture-fed and lot-fed sheep.

Authors:  Steven P Djordjevic; Vidiya Ramachandran; Karl A Bettelheim; Barbara A Vanselow; Peter Holst; Graham Bailey; Michael A Hornitzky
Journal:  Appl Environ Microbiol       Date:  2004-07       Impact factor: 4.792

9.  Epithelial and mesenchymal cells in the bovine colonic mucosa differ in their responsiveness to Escherichia coli Shiga toxin 1.

Authors:  Ivonne Stamm; Melanie Mohr; Philip S Bridger; Elmar Schröpfer; Matthias König; William C Stoffregen; Evelyn A Dean-Nystrom; Georg Baljer; Christian Menge
Journal:  Infect Immun       Date:  2008-09-02       Impact factor: 3.441

10.  The ether lipid precursor hexadecylglycerol protects against Shiga toxins.

Authors:  Jonas Bergan; Tore Skotland; Anne Berit Dyve Lingelem; Roger Simm; Bjørn Spilsberg; Toril Lindbäck; Tuulia Sylvänne; Helena Simolin; Kim Ekroos; Kirsten Sandvig
Journal:  Cell Mol Life Sci       Date:  2014-04-18       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.